EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Implementation of ML Flow for leprosy contacts in Brazil: Opportunities, pitfalls, and safeguards

Carolina Talhari iD, Claúdia Dos Passos Farias, Helio Amante Miot, Sinesio Talhari

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Carolina Talhari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências Aplicadas à Dermatologia, Universidade do Estado do Amazonas, Manaus, AM, Brazil. Hauptthemen laut MEDLINE: Leprosy, Antibodies, Bacterial, Glycolipids, Mycobacterium leprae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado do Amazonas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brazil has the second-highest leprosy burden worldwide, with approximately 20,000 new cases reported annually, many diagnosed with advanced disease and disability. To support earlier detection, the Ministry of Health recently approved the ML Flow rapid test for contact evaluation. ML Flow detects immunoglobulin M antibodies against phenolic glycolipid-I of Mycobacterium leprae , can be performed at the point of care using finger-prick blood, and yields results within minutes. ML Flow offers important operational advantages. It enables same-visit counseling and may support risk-stratified household-contact follow-up. However, its value is context-dependent. Because anti-phenolic glycolipid-I immunoglobulin M responses correlate with bacillary burden, positivity is more frequent in multibacillary disease, whereas many paucibacillary and pure neural cases have absent or low antibody levels. A seronegative result therefore does not exclude disease. Among asymptomatic contacts, seropositivity varies widely across studies, and in previously treated individuals antibodies may remain detectable for years. Available evidence suggests that seropositive contacts are at increased risk of incident leprosy, although predictive performance varies across settings. Serology alone is not diagnostic, and misuse may lead to stigma, anxiety, unnecessary referrals, and diversion of resources. The contribution of ML Flow is therefore implementation-dependent. In settings with standardized counseling, scheduled re-examination, and reliable referral pathways, it may support risk-stratified follow-up. In settings where these elements are weak, benefits may be limited. Brazil offers an important programmatic setting in which to evaluate this strategy, but only with safeguards: integration with dermato-neurological examination, clear protocols stating that seropositivity is not diagnostic, structured follow-up pathways, quality-controlled training, and systematic recording in the Brazilian Unified Health System information systems. Under these conditions, ML Flow may contribute to earlier diagnosis and disability reduction; without them, it risks adding workload without improving care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyAntibodies, BacterialGlycolipidsMycobacterium lepraeImmunoglobulin MContact TracingHumansBrazilAntigens, BacterialRapid Diagnostic Tests

Substanzen

Antibodies, BacterialGlycolipidsphenolic glycolipid I, Mycobacterium lepraeImmunoglobulin MAntigens, Bacterial

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Ciências Aplicadas à Dermatologia, Universidade do Estado do Amazonas, Manaus, AM, Brazil.
  • Fundação Hospitalar Alfredo da Matta de Dermatologia, Manaus, AM, Brazil.
  • Departamento de Dermatologia da FMB-UNESP, Botucatu, São Paulo, Brazil.

ORCID-Profile: Carolina Talhari

Förderung

  • Fundação de Amparo à Pesquisa do Estado do Amazonas

Zitieren

APA

Talhari, C., Farias, C. D. P., Miot, H. A., & Talhari, S. (2026). Implementation of ML Flow for leprosy contacts in Brazil: Opportunities, pitfalls, and safeguards. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014238

Vancouver

Talhari C, Farias CDP, Miot HA, Talhari S. Implementation of ML Flow for leprosy contacts in Brazil: Opportunities, pitfalls, and safeguards. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014238

BibTeX
@article{Talhari2026,
  author = {Talhari, Carolina and Farias, Claúdia Dos Passos and Miot, Helio Amante and Talhari, Sinesio},
  title = {Implementation of ML Flow for leprosy contacts in Brazil: Opportunities, pitfalls, and safeguards},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014238}
}
Kostenlos starten →